K Nakajima1, S W Lee, C Cocilovo, C Foglia, K Kim, T Sonoda, J W Milsom. 1. Section of Colon and Rectal Surgery, Department of Surgery, New York Presbyterian Hospital-Weill Medical College of Cornell University, 525 East 68th Street, New York, NY 10021, USA.
Abstract
BACKGROUND: An easily usable hand access device will optimize success in hand-assisted laparoscopic surgery (HALS). The authors describe their initial series of HALS colorectal resections using GelPort to evaluate their current technique and results with this new device. METHODS: A retrospective study investigated 33 HALS colorectal procedures including total colectomy ( n = 16) and low anterior resection ( n = 10). All operative data, including intraoperative GelPort performance, were prospectively recorded and retrospectively analyzed. RESULTS: In this study, 3 (9.1%) of 33 HALS procedures were converted to open surgery, and 4 (13.3%) of 30 HALS procedures required minimal enlargement of incisions to facilitate extracorporeal procedures. The operative time was 263 +/- 85 min, and the blood loss was 282 +/- 148 ml. There were no device malfunctions. Three major complications (9.1%) and 7 minor wound infections (21%) were noted postoperatively. The mean hospital stay was 7.9 +/- 3.8 days. CONCLUSION: When performed with GelPort, HALS is safely and reliably applicable for various colorectal procedures.
BACKGROUND: An easily usable hand access device will optimize success in hand-assisted laparoscopic surgery (HALS). The authors describe their initial series of HALS colorectal resections using GelPort to evaluate their current technique and results with this new device. METHODS: A retrospective study investigated 33 HALS colorectal procedures including total colectomy ( n = 16) and low anterior resection ( n = 10). All operative data, including intraoperative GelPort performance, were prospectively recorded and retrospectively analyzed. RESULTS: In this study, 3 (9.1%) of 33 HALS procedures were converted to open surgery, and 4 (13.3%) of 30 HALS procedures required minimal enlargement of incisions to facilitate extracorporeal procedures. The operative time was 263 +/- 85 min, and the blood loss was 282 +/- 148 ml. There were no device malfunctions. Three major complications (9.1%) and 7 minor wound infections (21%) were noted postoperatively. The mean hospital stay was 7.9 +/- 3.8 days. CONCLUSION: When performed with GelPort, HALS is safely and reliably applicable for various colorectal procedures.
Authors: E M Targarona; E Gracia; J Garriga; C Martínez-Bru; M Cortés; R Boluda; L Lerma; M Trías Journal: Surg Endosc Date: 2001-10-13 Impact factor: 4.584
Authors: D E Litwin; A Darzi; J Jakimowicz; J J Kelly; D Arvidsson; P Hansen; M P Callery; R Denis; D L Fowler; D S Medich; M J O'Reilly; H Atlas; J M Himpens; L L Swanstrom; E J Arous; P Pattyn; S M Yood; R Ricciardi; A Sandor; W C Meyers Journal: Ann Surg Date: 2000-05 Impact factor: 12.969
Authors: Imran Hassan; Y Nancy You; Robert R Cima; David W Larson; Eric J Dozois; S A Barnes; John H Pemberton Journal: Surg Endosc Date: 2008-03 Impact factor: 4.584
Authors: Sung Uk Bae; Jin Seok Park; Young Jin Choi; Min Ku Lee; Byung Sun Cho; Yoon Jung Kang; Joo Seung Park; Chang Nam Kim Journal: Ann Coloproctol Date: 2014-02-28